Resimac Group Limited (ASX:RMC)

Australia flag Australia · Delayed Price · Currency is AUD
1.175
-0.020 (-1.67%)
Feb 26, 2026, 12:40 PM AEST
Market Cap472.40M +16.9%
Revenue (ttm)163.59M +11.1%
Net Income34.58M -0.0%
EPS0.09 -0.1%
Shares Out395.31M
PE Ratio13.85
Forward PE8.99
Dividend0.07 (6.97%)
Ex-Dividend DateSep 4, 2025
Volume135,489
Average Volume120,042
Open1.190
Previous Close1.195
Day's Range1.170 - 1.205
52-Week Range0.810 - 1.225
Beta1.29
RSI79.07
Earnings DateFeb 24, 2026

About Resimac Group

Resimac Group Limited provides residential mortgage and asset finance lending products in Australia and New Zealand. The company operates through Home Loan Lending business, New Zealand Lending, and Asset Finance Lending segments. It offers prime and specialist lending products; SME/commercial finance products; and home, equipment, secured, novated leasing, and car loans. It also provides mortgage originator and trustee, lender, mortgage manager and broker, consumer and commercial lending, managed investment trust, and LMI captive insurer servi... [Read more]

Sector Financials
Founded 1985
Employees 300
Stock Exchange Australian Securities Exchange
Ticker Symbol RMC
Full Company Profile

Financial Performance

In fiscal year 2025, Resimac Group's revenue was 163.59 million, an increase of 11.08% compared to the previous year's 147.27 million. Earnings were 34.58 million, a decrease of -0.02%.

Financial Statements

News

Resimac Group Ltd (ASX:RMC) Full Year 2025 Earnings Call Highlights: Strategic Growth and ...

Resimac Group Ltd (ASX:RMC) Full Year 2025 Earnings Call Highlights: Strategic Growth and Shareholder Returns

6 months ago - GuruFocus

ASX 200 LIVE: Mayne Pharma shares plunge; CBA hits record; JHX sales, earnings slip amid AZEK buy; ASIC sues Resimac, sharemarket rises

Shares lift; CBA resets intraday record, tops $176; Mayne Pharma-Cosette tie-up hangs in balance; Nufarm plunges; James Hardie drops 5pc. Follow live.

10 months ago - The Australian Financial Review